收藏切换
Study of compound Shougong powder combined with zoledronic acid on bone metastasis of lung cancer through B lymphocyte induced maturation protein-1/B cell lymphoma factor 6 pathway
收藏切换
Liangjun ZHANG1, Qi CAI2, Silong ZHANG3, Jing HUANG1, Jinghai TIAN4, Liming XIA5
World Clinical Drug | 2023, 44(11) : 1152 - 1158
Less
收藏切换
World Clinical Drug | 2023, 44(11): 1152-1158
• Article •
Study of compound Shougong powder combined with zoledronic acid on bone metastasis of lung cancer through B lymphocyte induced maturation protein-1/B cell lymphoma factor 6 pathway
Full
Liangjun ZHANG1, Qi CAI2, Silong ZHANG3, Jing HUANG1, Jinghai TIAN4, Liming XIA5
Affiliations
  • 1.Department of Oncology, People's Hospital of Dongxihu District, Wuhan 430040, Hubei Province, China
  • 2.The First Clinical College, Anhui Medical University, Hefei 230032, Anhui Province, China
  • 3.School of Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, Hubei Province, China
  • 4.Department of Orthopedics, People's Hospital of Dongxihu District, Wuhan 430040, Hubei Province, China
  • 5.Department of Oncology, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei 230031, Anhui Province, China
Published: 2023-11-10 doi: 10.13683/j.wph.2023.11.004
Outline
收藏切换
Objective

To investigate the therapeutic effect of compound Shougong power combined with zoledronic acid on bone metastasis of lung cancer, and the effect on B lymphocyte induced maturation protein (Blimp)1/B cell lymphoma factor (Bcl)-6 pathway.

Methods

The mouse model of lung cancer bone metastasis was established and divided into bone metastasis group, low dose of traditional Chinese medicine (40 mg/kg compound Shougong powder) group, high dose of traditional Chinese medicine (120 mg/kg compound Shougong powder) group, western medicine (50 μg/kg zoledronic acid) group and combined treatment (120 mg/kg compound Shougong powder+50 μg/kg zoledronic acid) group, and set up sham operation group, with 10 mice in each group. After 21 days, tibial injury, pathological morphology, number of osteoclasts, in vivo imaging system fluorescence signal of bone metastasis and expression levels of Blimp1 and Bcl6 in tibial tissue were observed.

Results

Compared with the sham operation group, the number of osteoclasts, tumor cell fluorescence signals and Blimp1 expression in bone metastasis group were increased, while the Bcl-6 expression decreased (P<0.01). Compared with the bone metastasis group, the number of osteoclasts, tumor cell fluorescence signal and Blinp1 expression in the low and high dose traditional Chinese medicine groups and the western medicine group decreased, while Bcl-6 expression increased (P<0.01). Combination therapy enhanced the therapeutic effect of bone metastasis in lung cancer (P<0.01).

Conclusion

The combination of compound Shougong powder and zoledronic acid has a synergistic effect in the treatment of lung cancer bone metastasis, which may be related to the inhibition of the Blinmp1/Bcl-6 pathway.

compound Shougong powder  /  zoledronic acid  /  bone metastasis of lung cancer  /  B-lymphocyte-induced maturation protein-1/B-cell lymphoma factor 6 pathway
张良军, 蔡琪, 张思龙, 黄璟, 田敬海, 夏黎明. 复方守宫散联合唑来膦酸通过B淋巴细胞诱导成熟蛋白-1/B细胞淋巴瘤因子6通路对肺癌骨转移的研究. 世界临床药物, 2023 , 44 (11) : 1152 -1158 . DOI: 10.13683/j.wph.2023.11.004
Liangjun ZHANG, Qi CAI, Silong ZHANG, Jing HUANG, Jinghai TIAN, Liming XIA. Study of compound Shougong powder combined with zoledronic acid on bone metastasis of lung cancer through B lymphocyte induced maturation protein-1/B cell lymphoma factor 6 pathway[J]. World Clinical Drug, 2023 , 44 (11) : 1152 -1158 . DOI: 10.13683/j.wph.2023.11.004
Year 2023 volume 44 Issue 11
10
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.11.004
  • Receive Date:2022-08-22
  • Online Date:2026-11-18
  • Published:2023-11-10
Article Data
Affiliations
History
  • Received:2022-08-22
  • Revised:2023-09-19
Funding
Affiliations
    1.Department of Oncology, People's Hospital of Dongxihu District, Wuhan 430040, Hubei Province, China
    2.The First Clinical College, Anhui Medical University, Hefei 230032, Anhui Province, China
    3.School of Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, Hubei Province, China
    4.Department of Orthopedics, People's Hospital of Dongxihu District, Wuhan 430040, Hubei Province, China
    5.Department of Oncology, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei 230031, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.11.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT